• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

麻黄碱对能量摄入较低的肥胖女性有促进减肥的作用吗?

Does ephedrine promote weight loss in low-energy-adapted obese women?

作者信息

Pasquali R, Cesari M P, Melchionda N, Stefanini C, Raitano A, Labo G

出版信息

Int J Obes. 1987;11(2):163-8.

PMID:3301709
Abstract

A double-blind cross-over randomized study was performed in 10 selected adult overweight and obese (body mass index greater than 27) women who had been adapted to low-energy intake for a long period of time and who had shown difficulty in losing weight with conventional hypocaloric treatment. Combined with diet therapy (1000-1400 kcal/day), l(-)ephedrine hydrochloride (50 mg three times a day per os) or placebo were administered daily before each meal, after a period of stabilization with diet only for 1 month. Each pharmacological treatment lasted for 2 months. Weight loss was significantly (P less than 0.05) greater during the ephedrine period (2.41 +/- 0.61 kg) than during the placebo period (0.64 +/- 0.50 kg). None of the patients presented clinically important side-effects. These preliminary results seem to suggest a possible role for a thermogenic compound such as ephedrine in promoting weight loss in low-energy-adapted obese women.

摘要

对10名经过挑选的成年超重及肥胖(体重指数大于27)女性进行了一项双盲交叉随机研究。这些女性长期适应低能量摄入,且采用传统低热量疗法减肥困难。在仅通过饮食稳定1个月后,结合饮食疗法(1000 - 1400千卡/天),于每餐饭前每日口服给予盐酸l(-)麻黄碱(50毫克,每日三次)或安慰剂。每种药物治疗持续2个月。麻黄碱治疗期间体重减轻(2.41±0.61千克)显著(P小于0.05)大于安慰剂治疗期间(0.64±0.50千克)。没有患者出现具有临床意义的副作用。这些初步结果似乎表明,像麻黄碱这样的产热化合物在促进适应低能量的肥胖女性减肥方面可能发挥作用。

相似文献

1
Does ephedrine promote weight loss in low-energy-adapted obese women?麻黄碱对能量摄入较低的肥胖女性有促进减肥的作用吗?
Int J Obes. 1987;11(2):163-8.
2
The effect and safety of an ephedrine/caffeine compound compared to ephedrine, caffeine and placebo in obese subjects on an energy restricted diet. A double blind trial.在能量限制饮食的肥胖受试者中,麻黄碱/咖啡因复方与麻黄碱、咖啡因及安慰剂相比的效果和安全性。一项双盲试验。
Int J Obes Relat Metab Disord. 1992 Apr;16(4):269-77.
3
A controlled trial using ephedrine in the treatment of obesity.一项使用麻黄碱治疗肥胖症的对照试验。
Int J Obes. 1985;9(2):93-8.
4
Effects of chronic administration of ephedrine during very-low-calorie diets on energy expenditure, protein metabolism and hormone levels in obese subjects.极低热量饮食期间长期服用麻黄碱对肥胖受试者能量消耗、蛋白质代谢及激素水平的影响。
Clin Sci (Lond). 1992 Jan;82(1):85-92. doi: 10.1042/cs0820085.
5
The effects of orlistat on weight and on serum lipids in obese patients with hypercholesterolemia: a randomized, double-blind, placebo-controlled, multicentre study.奥利司他对高胆固醇血症肥胖患者体重及血脂的影响:一项随机、双盲、安慰剂对照、多中心研究。
Int J Obes Relat Metab Disord. 2001 Nov;25(11):1713-21. doi: 10.1038/sj.ijo.0801814.
6
X-PERT: weight reduction with orlistat in obese subjects receiving a mildly or moderately reduced-energy diet: early response to treatment predicts weight maintenance.X-PERT研究:接受轻度或中度能量减少饮食的肥胖受试者使用奥利司他减重:治疗早期反应可预测体重维持情况
Diabetes Obes Metab. 2005 Nov;7(6):699-708. doi: 10.1111/j.1463-1326.2005.00483.x.
7
Body fat loss achieved by stimulation of thermogenesis by a combination of bioactive food ingredients: a placebo-controlled, double-blind 8-week intervention in obese subjects.通过生物活性食品成分组合刺激产热实现身体脂肪减少:一项针对肥胖受试者的安慰剂对照、双盲8周干预研究。
Int J Obes (Lond). 2007 Jan;31(1):121-30. doi: 10.1038/sj.ijo.0803351. Epub 2006 Apr 25.
8
The effect of ephedrine plus caffeine on plasma lipids and lipoproteins during a 4.2 MJ/day diet.在每日4.2兆焦耳饮食期间,麻黄碱加咖啡因对血浆脂质和脂蛋白的影响。
Int J Obes Relat Metab Disord. 1994 May;18(5):329-32.
9
Effect of ephedrine and theophylline on weight loss, resting energy expenditure and lipoprotein lipase activity in obese over-fed rats.麻黄碱和茶碱对肥胖过度喂养大鼠体重减轻、静息能量消耗及脂蛋白脂肪酶活性的影响。
Int J Obes Relat Metab Disord. 1993 Jun;17(6):343-7.
10
Effect of hypocaloric diet plus sibutramine treatment on hormonal and metabolic features in overweight and obese women with polycystic ovary syndrome: a randomized, 24-week study.低热量饮食联合西布曲明治疗对超重及肥胖多囊卵巢综合征女性激素和代谢特征的影响:一项随机、为期24周的研究
Int J Obes (Lond). 2008 Apr;32(4):692-9. doi: 10.1038/sj.ijo.0803777. Epub 2007 Dec 11.

引用本文的文献

1
Combination drugs for treating obesity.治疗肥胖的联合药物。
Curr Diab Rep. 2010 Apr;10(2):108-15. doi: 10.1007/s11892-010-0096-4.
2
Pharmacotherapy for weight loss in adults with type 2 diabetes mellitus.2型糖尿病成年患者体重减轻的药物治疗
Cochrane Database Syst Rev. 2005 Jan 25;2005(1):CD004096. doi: 10.1002/14651858.CD004096.pub2.
3
Obesity. Part II--Treatment.肥胖症。第二部分——治疗。
West J Med. 1988 Nov;149(5):555-71.